Calyx Bio-Ventures Inc. (TSXV:CYX) announced a non-brokered private placement of 5,715,856 units at CAD 0.07 per unit for gross proceeds of CAD 400,110 on October 31, 2016. Each unit will comprise of one common share and one-half of one common share purchase warrant. Each warrant will entitle the holder to acquire one additional common share at a price of CAD 0.15 per share until 24 months from closing. Securities to be issued are subject to a four month plus one day hold period expiring on March 1, 2017.